Network-based analysis of glioblastoma identifies patient communities and cluster-specific biomarkers

Glioblastoma is an aggressive and highly heterogeneous brain tumor with poor prognosis despite multimodal treatment strategies. Understanding the molecular diversity of the disease is essential for improving tumor stratification and identifying potential therapeutic targets. In this study, we investigate whether network-based analysis can reveal biologically meaningful subgroups of glioblastoma tumors. Using RNA sequencing and mutation data from the TCGA-GBM cohort, we constructed patient-specific protein–protein interaction networks based on genes that are differentially expressed or harbor somatic mutations. These networks capture the molecular alterations associated with individual tumors within the context of the human interactome. We then derived similarities between tumors using a binary representation of network nodes and the Jaccard similarity metric, enabling the construction of a patient similarity graph. Community detection algorithms (Louvain and Leiden) were applied to this graph to identify clusters of tumors with similar molecular network profiles. Our analysis revealed six tumor communities characterized by distinct gene compositions and enriched biological processes. For each community, we identified candidate biomarkers and network hubs that may represent potential therapeutic targets. Several of the identified genes correspond to known drug targets, while others represent potential candidates for further investigation.

These results illustrate how integrating molecular alterations with network-based modeling can help stratify glioblastoma tumors and uncover molecular mechanisms that may guide the development of more personalized therapeutic strategies.